Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management
- PMID: 17482847
- DOI: 10.1016/j.tripleo.2007.01.008
Biphosphonate-associated osteonecrosis can be controlled by nonsurgical management
Abstract
Sixteen patients with jaw biphosphonate-osteonecrosis and with exposed bone areas were subdivided into 2 treatment groups. The first group (7 patients) underwent superficial or radical surgical therapy, while the second (9 patients) underwent antibiotic treatment. A slight reduction of the necrotic areas was observed in 5 of 7 patients in the first group, whereas no change was observed in the remaining 2 patients at 22- and 24-month follow-up. A slight reduction of the necrotic areas was observed in 7 of 9 patients in the second group, whereas no change was observed in the remaining 2 patients at 5- and 24-month follow-up. The statistical analysis showed that the treatment regimen did not significantly influence the dimensional change in the exposed bone. The preliminary results seem to suggest that biphosphonate-associated osteonecrosis can be well controlled by a nonsurgical protocol consisting in long-term administration of antibiotics.
Similar articles
-
Bisphosphonate treatment as a cause of jaw osteonecrosis.Oral Dis. 2007 May;13(3):346-7. doi: 10.1111/j.1601-0825.2007.01320.x. Oral Dis. 2007. PMID: 17448221 No abstract available.
-
Orofacial pain - a presenting symptom of bisphosphonate associated osteonecrosis of the jaws.Br Dent J. 2007 Jul 28;203(2):91-2. doi: 10.1038/bdj.2007.635. Br Dent J. 2007. PMID: 17660779
-
Bisphosphonate-induced osteonecrosis of the jaw 32 months after interruption of zoledronate in a patient with multiple myeloma.J Oral Maxillofac Surg. 2010 May;68(5):1179-82. doi: 10.1016/j.joms.2009.08.005. Epub 2010 Feb 24. J Oral Maxillofac Surg. 2010. PMID: 20185222 No abstract available.
-
Osteonecrosis of the jaw related to the use of bisphosphonates.Curr Opin Oncol. 2007 Jul;19(4):315-22. doi: 10.1097/CCO.0b013e32819f820b. Curr Opin Oncol. 2007. PMID: 17545793 Review.
-
Bisphosphonates and osteonecrosis of the jaws.J Dent Educ. 2008 Aug;72(8):919-29. J Dent Educ. 2008. PMID: 18676801 Review.
Cited by
-
Conservative non-surgical management in medication related osteonecrosis of the jaw: A retrospective study.Clin Exp Dent Res. 2020 Oct;6(5):512-518. doi: 10.1002/cre2.303. Epub 2020 Jul 2. Clin Exp Dent Res. 2020. PMID: 32614524 Free PMC article.
-
Bisphosphonate-related osteonecrosis: laser-assisted surgical treatment or conventional surgery?Lasers Med Sci. 2011 Nov;26(6):815-23. doi: 10.1007/s10103-011-0974-2. Epub 2011 Aug 2. Lasers Med Sci. 2011. PMID: 21809068 Clinical Trial.
-
Effect of hyperbaric oxygen therapy on tooth extraction sites in rats subjected to bisphosphonate therapy-histomorphometric and immunohistochemical analysis.Clin Oral Investig. 2017 Jan;21(1):199-210. doi: 10.1007/s00784-016-1778-3. Epub 2016 Mar 9. Clin Oral Investig. 2017. PMID: 26955837
-
Fibular flap mandibular reconstruction for third-stage medication-related osteonecrosis of the jaw: A retrospective single-center study.J Dent Sci. 2023 Jul;18(3):976-984. doi: 10.1016/j.jds.2022.12.015. Epub 2023 Jan 2. J Dent Sci. 2023. PMID: 37404597 Free PMC article.
-
Combined Approach to Treat Medication-Related Osteonecrosis of the Jaws.J Lasers Med Sci. 2018 Spring;9(2):92-100. doi: 10.15171/jlms.2018.19. Epub 2018 Mar 20. J Lasers Med Sci. 2018. PMID: 30026893 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical